drugset / Trial / NCT06807580
Progesterone in Gender Affirming Hormone Therapy Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to study the effects of Oral Progesterone in Transgender Women. The primary goal is to study the effect of progesterone on psychological distress and secondarily on sleep quality, breast size, quality of life and gender congruence and cardiovascular risk.
Timeline
- Start
- 2025-05-12
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.